Cleared Abbreviated

K091123 - ADVIA CENTAUR DHEAS MASTER CURVE MATERIALS

K091123 is an FDA 510(k) clearance for ADVIA CENTAUR DHEAS MASTER CURVE MATERIALS, manufactured by Siemens Healthcare Diagnostics. The device is a Class 1 Chemistry device with product code JJX cleared through the Abbreviated 510(k) pathway after a 119-day FDA review.

K091123 · Siemens Healthcare Diagnostics · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2009
Decision
119d
Days
Class 1
Risk

K091123 is an FDA 510(k) clearance for the ADVIA CENTAUR DHEAS MASTER CURVE MATERIALS. Classified as Single (specified) Analyte Controls (assayed And Unassayed) (product code JJX), Class I - General Controls.

Submitted by Siemens Healthcare Diagnostics (Tarrytown, US). The FDA issued a Cleared decision on August 14, 2009 after a review of 119 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1660 - the FDA in vitro diagnostics and chemistry framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Siemens Healthcare Diagnostics devices

FDA 510(k) Submission Details - K091123

510(k) Number K091123 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 17, 2009
Decision Date August 14, 2009
Days to Decision 119 days
Submission Type Abbreviated
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
31d slower than avg
Panel avg: 88d · This submission: 119d
Pathway characteristics
Standards-based clearance path.

JJX Device Classification - Class 1, General Controls

Product Code JJX Single (specified) Analyte Controls (assayed And Unassayed)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JJX Single (specified) Analyte Controls (assayed And Unassayed)

All 402
Devices cleared under the same product code (JJX) and FDA review panel - the closest regulatory comparables to K091123.
ELECYS ANTI-CCP CALCHECK
K091601 · Roche Diagnostics Corp. · Sep 2009
LIAISON 25 OH VITAMIN D TOTAL CALIBRATION VERIFIERS, MODEL: 310603
K090104 · DiaSorin, Inc. · Sep 2009
FDI GLUCOSE CONTROL LEVELS 1, 2 AND 3
K092645 · Fujirebio Diagnostics,Inc. · Sep 2009
ELECSYS RUBELLA IGG CALCHECK
K090311 · Roche Diagnostics · May 2009
ELECSYS TOXO IGG CALCHECK
K083655 · Roche Diagnostics · Feb 2009
RNA MEDICAL GLUCOSE AND B-KETONE CALIBRATION VERIFICATION CONTROLS
K081478 · Bionostics, Inc. · Oct 2008